This acquisition marking Fujirebio’s entry into the controls and calibrators manufacturing business will enable the company to further strengthen its position in the evolving in vitro diagnostics industry.
Monte Wiltse, vice president of marketing and sales of Fujirebio Diagnostics, said: “By combining American Biological Technologies’s control products and manufacturing capabilities with Fujirebio Diagnostics’s extensive knowledge of in-vitro diagnostics, marketing resources and established customer relationships and partnerships, we’ll truly be able to realize the potential for the American Biological Technologies product offering to take our business to the next level of disease diagnostics.”